ESR1/2 might directly or indirectly regulate oncogenic pathways in non-small-cell lung cancer, and FOXO1 expression is a favourable prognostic factor in non-small-cell lung cancer30,31. Here, FOXO1 is linked to non-small cell lung carcinoma.